Arcadia Bio (RKDA) Net Sales Margin

Corporate emblem and logo of Arcadia Biosciences (RKDA)

Arcadia Biosciences relies on external contractors for grain production, which creates operational dependency. Revenues are based on the commercialization of GMO crops and market demand. The GoodWheat product line is currently undergoing an active monetization phase. The core operating net margin reflects the business's profitability dynamics, and -202.10 expresses the latest metric level, helping to assess the quality of the asset.

Arcadia Biosciences (RKDA) - Net Profit Rate from 07/04/2022 to 11/20/2026

Analytical breakdowns for Arcadia Biosciences

Fundamental valuation:Arcadia Biosciences
Manufactured product of Arcadia Bio

The long-term reliability of Arcadia Biosciences (RKDA) is determined by the business's ability to generate net profit after covering all operating and financial obligations. This metric measures the portion of every dollar of revenue remaining available to shareholders. By analyzing the net margin, an investor assesses cost management efficiency and debt service costs. The stability of this indicator is supported by cost optimization through the outsourcing of crop cultivation. The diversification of farming sites minimizes raw material risks, maintaining the sustainability of final profitability.